drugset
drugset / Trial / NCT04502277

Bioavailability of Flucanazole

NCT04502277 ↗

Phase 0 Unknown 200 enrolled Sutphin Drugs
RandomizedCrossoverOpen-labelOther

Summary

The Objective of This Study Was an Open-label, Randomized, 2-way Crossover to Compare the Single-dose Relative Bioavailability of Flucanazole 40mgm/ml 35 ml Suspension and Pfizer (Diflucan®) 40 mg/ml 35 ml Fluconazole Suspension Under Fed Condition

Timeline

Start
2020-09-01
Primary completion
2020-12-31
Completion
2021-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule 35 ml —
Subject Fluconazole Small molecule 40 mg/ml —

Indications

candidiasis